Medpage Today on MSN2d
Some Psoriasis Biologics Better Than Others for Preventing Progression to PsA
Psoriasis was less likely to progress to psoriatic arthritis (PsA) among patients treated with interleukin-17 (IL-17) or ...
pharmaphorum6d
UCB’s bimekizumab tops J&J’s Stelara in psoriasis study
It was better than Stelara in reaching ... impacting the lives of psoriasis patients,” he added. BE VIVID will follow patients for a year after starting treatment, so additional readouts will ...
Healthline22d
6 Benefits of Trying a New Psoriasis Treatment
The psoriasis treatment that works for you initially ... notice better results with infliximab (Remicade) or ustekinumab (Stelara) than other biologics because the dosing of these drugs is based ...
Drug Store News1d
Unsure and Uncertain
In November, Amneal received FDA approval for exenatide, its first generic injectable glucagon-like peptide-1 (GLP-1) agonist ...
The American Journal of Managed Care24d
Ustekinumab Biosimilar Launches in France, Shifts the Autoimmune Disease Market
2 The FDA approval in December 2024 was based on phase 3 study results that compared the efficacy and safety of CT-P43 with Stelara in patients with plaque psoriasis (NCT04673786). Steqeyma was ...